This inventor holds 2 USPTO granted patents. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 2000-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gottingen, DE (2000)
- Göttingen, DE (2002)
Company Filing History:
Years Active: 2000-2002
Title: Martin G Dunkel: Innovator in Pyrimidine Nucleosides
Introduction
Martin G Dunkel is a notable inventor based in Göttingen, Germany. He has made significant contributions to the field of chemistry, particularly in the development of pyrimidine nucleosides. His work has led to advancements that are crucial for various applications in biochemistry and molecular biology.
Latest Patents
Dunkel holds 2 patents related to novel pyrimidine nucleosides. His latest patents include innovative compounds that feature 2- and 4-substituted pyrimidine nucleosides and oligonucleosides. These patents provide methods and intermediates useful in preparing these compounds, which have potential applications in therapeutic and diagnostic fields.
Career Highlights
Martin G Dunkel is associated with Isis Pharmaceuticals, Inc., where he has been instrumental in research and development. His expertise in nucleoside chemistry has positioned him as a key figure in the advancement of new therapeutic agents.
Collaborations
Throughout his career, Dunkel has collaborated with notable colleagues, including Phillip Dan Cook and Oscar L Acevedo. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Martin G Dunkel's contributions to the field of pyrimidine nucleosides exemplify the impact of innovative research in chemistry. His patents and collaborations continue to influence advancements in biochemistry and molecular biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile